Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
India
/
Healthcare
/
Krishna Institute of Medical Sciences
KIMS
Krishna Institute of Medical Sciences
Urban Expansion Will Trigger Integration Risks And Regulatory Hurdles
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 13 Analysts
Published
24 Jul 25
Updated
24 Jul 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
₹630.00
15.3% overvalued
intrinsic discount
24 Jul
₹726.50
Loading
1Y
61.8%
7D
-2.8%
Author's Valuation
₹630.0
15.3% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
₹630.0
15.3% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-477m
57b
2015
2017
2019
2021
2023
2025
2027
2028
Revenue ₹57.3b
Earnings ₹8.1b
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
22.65%
Healthcare Services revenue growth rate
0.29%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
12.73%
Calculation
₹8.05b
Earnings '28
x
44.72x
PE Ratio '28
=
₹360.16b
Market Cap '28
₹360.16b
Market Cap '28
/
402.60m
No. shares '28
=
₹894.59
Share Price '28
₹894.59
Share Price '28
Discounted to 2025 @ 12.55% p.a.
=
₹627.49
Fair Value '25